September 15, 2014

New COPD Medicines captured in useful COPD decision support tool

LFA Stepwise Management of COPD 300pxSo far this year there have been three new medicines released for patients with COPD.

These include:

  • Glycopyrronium bromide (Seebri), once daily LAMA
  • Aclidinium bromide (Bretaris), twice daily LAMA. The Genuair is the inhaler device for Bretaris. To view the inhaler device video contact Judy on 1800 654 301 or enquiries@lungfoundation.com.au.
  • Indacaterol/glycopyrronium bromide (Ultibro), once daily LABA/LAMA

The Stepwise Management of Stable COPD is a one page evidence-based decision support tool outlining pharmacotherapy and non-pharmacotherapy options across the level of disease severity. Download the latest version of Stepwise Management of Stable COPD here <http://lungfoundation.com.au/wp-content/uploads/2014/02/LFA-Stepwise-Management-of-COPD_0216_WEB-1.pdf> to find out when medicines can be introduced and precautions around using them in combination.

Visit the website for the COPDX Guidelines www.copdx.org.au